Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2020Frontiers in Molecular NeuroscienceOpen Access

Downregulation of the CB1-Mediated Endocannabinoid Signaling Underlies D-Galactose-Induced Memory Impairment

View Full Paper
Ask AI
Bookmark
Share

Authors

RLRanran LiZHZhi HuangLJLuo Juan

Discussion

Loading...

Member takes

Overview

Animal study uncovers CB1 signaling downregulation driving memory loss in D-galactose-treated rats, indicating that balancing redox and endocannabinoid systems may treat cognitive decline.

Key Points

  • To investigate the causal link between oxidative stress and endocannabinoid system dysregulation in driving synaptic plasticity impairment and memory loss.
  • Induced oxidative stress in rats using D-galactose and assessed spatial memory with behavioral tests.
  • Measured hippocampal long-term potentiation alongside the expression of nitric oxide synthase, CB1 receptors, and anandamide-degrading enzymes.
  • Assessed electrophysiological plasticity following treatment with low-dose anandamide and the nitric oxide synthase inhibitor diphenyleneiodonium.
  • D-galactose administration significantly increased reactive oxygen species-generating enzymes, particularly nitric oxide synthase, which correlated with impaired hippocampal long-term potentiation and spatial memory loss.
  • Treated rats showed decreased CB1 expression and increased anandamide-degrading enzymes, leading low-dose anandamide to paradoxically enhance long-term potentiation through GABAergic inhibition.
  • Diphenyleneiodonium-mediated inhibition of nitric oxide synthase fully replicated the altered CB1-signaling response observed in the oxidative stress model.

Cite This Study

Li et al. (2020) studied this question.

synapsesocial.com/papers/69d8ffeff544bba627bedad2https://doi.org/10.3389/fnmol.2020.00130
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1D-galactose-induced Cognitive Impairment: Mechanism, Models and Therapeutic Interventions2026
  2. 2Insights into Gastrointestinal Redox Dysregulation in a Rat Model of Alzheimer’s Disease and the Assessment of the Protective Potential of D-Galactose2024 · 4 citations
  3. 3Cyanidin-3-O-Glucoside Protects Against Cognitive Impairment in D-Galactose-Induced Aging Mice by Regulating Nrf2 and NF-κB Pathways2026
  4. 4Chronic systemic injection of D-galactose impairs the septohippocampal cholinergic system in rats2008 · 40 citations
  5. 5Investigating the protective effect of zinc oxide–gallic acid nanoparticles against depression like behavior and memory impairment in animals treated with D-galactose2026